My watch list
my.bionity.com  
Login  

Kernicterus



Kernicterus
Classification & external resources
Bilirubin
ICD-10 P57.
ICD-9 773.4, 774.7
DiseasesDB 7161
MedlinePlus 003243
eMedicine ped/1247 
MeSH D007647

Kernicterus is damage to the brain centers of infants caused by elevated levels of bilirubin. This may be due to several underlying pathologic processes. Newborn babies are often polycythemic, meaning they have too many red blood cells. When they break down the cells, one of the byproducts is bilirubin, which circulates in the blood, and causes jaundice. Alternately, Rh incompatibility between mother and fetus may cause hemolysis of fetal red blood cells, thereby releasing unconjugated bilirubin into the fetal blood. Since the fetal blood brain barrier is not fully formed, some of this released bilirubin enters the brain and interferes with normal neuronal development.

In adults and older children, jaundice is harmless in and of itself. However, the tissues protecting the brain (the blood-brain barrier) are immature in newborns. Bilirubin penetrates the brain and is deposited in the basal ganglia, causing irreversible damage. Depending on the level of exposure, the effects range from unnoticeable to severe brain damage.

Some medications, such as co-trimoxazole, a combination of trimethoprim/sulfamethoxazole may induce this disorder to the baby when taken by the mother or given directly to the baby. Due to displacement of of bilirubin from binding sites on serum albumin. The bilirubin is then free to pass into the Central Nervous System, because the baby's blood-brain barrier is not fully developed.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Kernicterus". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE